TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
OCUL

Ocular Therapeutix Inc

Healthcare · Biotechnology

10.00$ +0.0% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement OCUL
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+126.7% +7.8% +1.9% +3.5% +112.4% +311.7% +150.1% +18.3% +13.5% +9.0% -18.7%
+250.5% +38.9% +3.2% +1.8% +400.0% -10.4% +111.5% +3.0% +16.3% +6.5% +16.9%
+110.1% +0.9% +1.5% +4.0% +24.7% +705.5% +155.3% +20.0% +13.2% +9.3% -22.1%
+40.9% +1.7% +14.1% +19.5% +11.3% -30.2% +74.5% +6.7% +14.2% +109.0% +54.4%
+32.6% +20.1% +40.9% +21.1% +17.8% +3.3% +39.5% +113.2% -50.1% +78.7% +6.1%
+42.7% +13.0% +41.6% -4.3% +44.6% -10.9% +49.9% +7.2% +7.9% +69.6% +37.2%
+54.1% -2.6% +12.6% -8.1% +250.8% +10.9% -1.4% +5.3% +61.5% +19.7% -12.8%
+651.5% -18.3% -65.9% -940.4% +12.1% +6.4% -279.2%
-2,538.2%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?